Cell-penetrating peptides (CPPs) as therapeutic and diagnostic agents for cancer

RA Bottens, T Yamada - Cancers, 2022 - mdpi.com
Simple Summary Crossing biological barriers is often required for drug delivery. Cell-
penetrating peptides (CPPs) are short strands of amino acids that have been widely used as …

p28 bacterial peptide, as an anticancer agent

A Yaghoubi, M Khazaei, A Avan, SM Hasanian… - Frontiers in …, 2020 - frontiersin.org
Cancer remains a major cause of morbidity and mortality irrespective of the type of
conventional chemotherapy. Therefore, there is an urgent need for new and effective …

Automated assembly of molecular mechanisms at scale from text mining and curated databases

JA Bachman, BM Gyori, PK Sorger - Molecular Systems Biology, 2023 - embopress.org
The analysis of omic data depends on machine‐readable information about protein
interactions, modifications, and activities as found in protein interaction networks, databases …

p28-Mediated Activation of p53 in G2–M Phase of the Cell Cycle Enhances the Efficacy of DNA Damaging and Antimitotic Chemotherapy

T Yamada, TK Das Gupta, CW Beattie - Cancer research, 2016 - AACR
Abstract p28 is an anionic cell-penetrating peptide of 28 amino acids that activates wild-type
and mutated p53, leading subsequently to selective inhibition of CDK2 and cyclin A …

Novel perspective for protein–drug interaction analysis: atomic force microscope

H Sun, J Wang - Analyst, 2023 - pubs.rsc.org
Proteins are major drug targets, and drug–target interaction identification and analysis are
important factors for drug discovery. Atomic force microscopy (AFM) is a powerful tool …

Bacterial cupredoxin azurin hijacks cellular signaling networks: protein–protein interactions and cancer therapy

M Gao, J Zhou, Z Su, Y Huang - Protein Science, 2017 - Wiley Online Library
Azurin secreted by Pseudomonas aeruginosa is an anticancer bacteriocin, which
preferentially enters human cancer cells and induces apoptosis or growth inhibition. It turns …

Disassembling a cancer puzzle: Cell junctions and plasma membrane as targets for anticancer therapy

ON Shilova, ES Shilov, A Lieber, SM Deyev - Journal of controlled release, 2018 - Elsevier
Despite an enhanced permeability and retention effect typical of many solid tumors, drug
penetration is not always sufficient. Possible strategies for the drug delivery improvement …

Single-molecule scale quantification reveals interactions underlying protein–protein interface: from forces to non-covalent bonds

H Sun, Y Tian, Y Fu, Y Lei, Y Wang, X Yan… - Physical Chemistry …, 2023 - pubs.rsc.org
Protein–protein interactions (PPIs) between the B-cell lymphoma 2 (Bcl-2) family are
considered a major driving force in cell cycle regulation and signaling. However, how this …

Dual role of p73 in cancer microenvironment and DNA damage response

JM Rozenberg, S Zvereva, A Dalina, I Blatov, I Zubarev… - Cells, 2021 - mdpi.com
Understanding the mechanisms that regulate cancer progression is pivotal for the
development of new therapies. Although p53 is mutated in half of human cancers, its family …

Surface plasmon resonance sensing of biorecognition interactions within the tumor suppressor P53 network

I Moscetti, S Cannistraro, AR Bizzarri - Sensors, 2017 - mdpi.com
Surface Plasmon Resonance (SPR) is a powerful technique to study the kinetics of
biomolecules undergoing biorecognition processes, particularly suited for protein-protein …